Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathieu Mateo

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Journal of Virology|May 11, 2026
Lassa and Mopeia viruses produce different RIG-I-activating RNA in the absence of a functional viral exoribonuclease domainKodie Noy, Rachel Legendre, Séverine Croze, et al.
Life Science Alliance|February 28, 2024
Stable structures or PABP1 loading protects cellular and viral RNAs against ISG20-mediated decayCamille Louvat, Séverine Deymier, Xuan-Nhi Nguyen, et al.
JCI Insight|January 11, 2019
Immune parameters and outcomes during Ebola virus diseaseStéphanie Reynard, Alexandra Journeaux, Emilie Gloaguen, et al.
Journal of Virology|May 1, 2015
The Nectin-4/Afadin Protein Complex and Intercellular Membrane Pores Contribute to Rapid Spread of Measles Virus in Primary Human Airway EpitheliaBrajesh K Singh, Andrew L Hornick, Sateesh Krishnamurthy, et al.
Nature Communications|January 5, 2020
Rational design of universal immunotherapy for TfR1-tropic arenavirusesHadas Cohen-Dvashi, Ron Amon, Krystle N Agans, et al.
Journal of Virology|March 30, 2018
A Vaccine Platform against Arenaviruses Based on a Recombinant Hyperattenuated Mopeia Virus Expressing Heterologous GlycoproteinsXavier Carnec, Mathieu Mateo, Audrey Page, et al.
Lancet (London, England)|March 19, 2023
Immunogenicity, safety, and tolerability of a recombinant measles-vectored Lassa fever vaccine: a randomised, placebo-controlled, first-in-human trialRoland Tschismarov, Pierre Van Damme, Clara Germain, et al.
Cell Reports|March 18, 2014
Marburgvirus hijacks nrf2-dependent pathway by targeting nrf2-negative regulator keap1Audrey Page, Valentina A Volchkova, Saint Patrick Reid, et al.
Emerging Infectious Diseases|August 24, 2019
Fatal Case of Lassa Fever, Bangolo District, Côte d'Ivoire, 2015Mathieu Mateo, Caroline Picard, Yahaya Sylla, et al.
Plos Biology|July 3, 2024
SAMD9L acts as an antiviral factor against HIV-1 and primate lentiviruses by restricting viral and cellular translationAlexandre Legrand, Clara Dahoui, Clément De La Myre Mory, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Journal of Virology|May 11, 2026
Lassa and Mopeia viruses produce different RIG-I-activating RNA in the absence of a functional viral exoribonuclease domainKodie Noy, Rachel Legendre, Séverine Croze, et al.
Life Science Alliance|February 28, 2024
Stable structures or PABP1 loading protects cellular and viral RNAs against ISG20-mediated decayCamille Louvat, Séverine Deymier, Xuan-Nhi Nguyen, et al.
JCI Insight|January 11, 2019
Immune parameters and outcomes during Ebola virus diseaseStéphanie Reynard, Alexandra Journeaux, Emilie Gloaguen, et al.
Journal of Virology|May 1, 2015
The Nectin-4/Afadin Protein Complex and Intercellular Membrane Pores Contribute to Rapid Spread of Measles Virus in Primary Human Airway EpitheliaBrajesh K Singh, Andrew L Hornick, Sateesh Krishnamurthy, et al.
Nature Communications|January 5, 2020
Rational design of universal immunotherapy for TfR1-tropic arenavirusesHadas Cohen-Dvashi, Ron Amon, Krystle N Agans, et al.
Journal of Virology|March 30, 2018
A Vaccine Platform against Arenaviruses Based on a Recombinant Hyperattenuated Mopeia Virus Expressing Heterologous GlycoproteinsXavier Carnec, Mathieu Mateo, Audrey Page, et al.
Lancet (London, England)|March 19, 2023
Immunogenicity, safety, and tolerability of a recombinant measles-vectored Lassa fever vaccine: a randomised, placebo-controlled, first-in-human trialRoland Tschismarov, Pierre Van Damme, Clara Germain, et al.
Cell Reports|March 18, 2014
Marburgvirus hijacks nrf2-dependent pathway by targeting nrf2-negative regulator keap1Audrey Page, Valentina A Volchkova, Saint Patrick Reid, et al.
Emerging Infectious Diseases|August 24, 2019
Fatal Case of Lassa Fever, Bangolo District, Côte d'Ivoire, 2015Mathieu Mateo, Caroline Picard, Yahaya Sylla, et al.
Plos Biology|July 3, 2024
SAMD9L acts as an antiviral factor against HIV-1 and primate lentiviruses by restricting viral and cellular translationAlexandre Legrand, Clara Dahoui, Clément De La Myre Mory, et al.
Pageof 5